| 2D Structure | |
| CID | 6047 |
| IUPAC Name | (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid |
| InChI | InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1 |
| InChI Key | WTDRDQBEARUVNC-LURJTMIESA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C9H11NO4 |
| Molecular Weight | 197.19 |
| synonyms | ['levodopa', 'L-dopa', '59-92-7', '3,4-dihydroxy-L-phenylalanine', 'Dopar', '3-Hydroxy-L-tyrosine', 'Bendopa', 'Larodopa', '3-(3,4-Dihydroxyphenyl)-L-alanine', 'Levopa', 'Brocadopa', 'Cidandopa', 'Dopaidan', 'Dopalina', 'Insulamina', 'Maipedopa', 'Dopasol', 'Eldopal', 'Eldopar', 'Pardopa', 'Prodopa', 'Syndopa', 'Helfo-Dopa', '(-)-Dopa', 'Dihydroxy-L-phenylalanine', 'Deadopa', 'Dopaflex', 'Doparkine', 'Dopaston', 'Dopastral', 'Eldopatec', 'Eurodopa', 'Doparl', 'Doprin', 'Veldopa', '(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid', 'L-3,4-Dihydroxyphenylalanine', 'Levodopum', 'L-o-Hydroxytyrosine', 'L-Tyrosine, 3-hydroxy-', 'Ledopa', '(-)-3-(3,4-Dihydroxyphenyl)-L-alanine', 'Dopaston SE', 'beta-(3,4-Dihydroxyphenyl)-L-alanine', '3,4-Dihydroxyphenyl-L-alanine', 'Laradopa', 'Sobiodopa', 'Biodopa', 'Cerepap', 'Parda', 'L-(-)-Dopa', 'L-beta-(3,4-Dihydroxyphenyl)alanine', 'L-Dihydroxyphenylalanine', 'Helfo DOPA', 'Inbrija', 'Ro 4-6316', 'beta-(3,4-Dihydroxyphenyl)alanine', 'L Dopa', 'L-O-Dihydroxyphenylalanine', 'CVT-301', 'alanine, 3-(3,4-dihydroxyphenyl)-, L-', 'CHEBI:15765', 'L(-)-Dopa', 'beta-(3,4-Dihydroxyphenyl)-alpha-L-alanine', 'L-beta-(3,4-Dihydroxyphenyl)-alpha-alanine', 'Alanine, 3-(3,4-dihydroxyphenyl)-, (-)-', 'NSC-118381', 'DTXSID9023209', 'beta-(3,4-Dihydroxyphenyl)-alpha-alanine', 'NSC118381', 'DHIVY COMPONENT LEVODOPA', 'DTXCID303209', 'DUOPA COMPONENT LEVODOPA', 'RYTARY COMPONENT LEVODOPA', '46627O600J', 'CREXONT COMPONENT LEVODOPA', 'STALEVO COMPONENT LEVODOPA', 'CORBILTA COMPONENT LEVODOPA', 'V-1512', '(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate', 'LEVODOPA/CARBIDOPA/ENTACAPONE ORION COMPONENT LEVODOPA', '3 Hydroxy L tyrosine', 'L 3,4 Dihydroxyphenylalanine', 'L-Dopa Phenolic', 'RefChem:6454', 'L DOPA 4X', 'L-Dopa 1514', 'N04BA01', '(--)-3-(3,4-Dihydroxyphenyl)-L-alanine', '(--)-2Amino-3-(3,4-dihydroxyphenyl)propanoic Acid', '200-445-2', '(2S)-2-azaniumyl-3-(3,4-dihydroxyphenyl)propanoate', '3,4-Dihydroxyphenylalanine', 'Dopal-fher', 'Dopa', 'Levedopa', 'L-(o-Dihydroxyphenyl)alanine', 'L-3-Hydroxytyrosine', 'MFCD00002598', 'Weldopa', 'L-3-(3,4-Dihydroxyphenyl)alanine', 'Parcopa', '(S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid', 'component of Sinemet', 'Dopar (TN)', '(-)-(3,4-Dihydroxyphenyl)alanine', 'L-.beta.-(3,4-Dihydroxyphenyl)alanine', 'CHEMBL1009', '.beta.-(3,4-Dihydroxyphenyl)-L-alanine', 'L-(3,4-Dihydroxyphenyl)alanine', '.beta.-(3,4-Dihydroxyphenyl)alanine', 'CAS-59-92-7', 'NCGC00016270-04', 'L-(3,4-Dihydroxyphenyl)-.alpha.-alanine', 'Phenylalanine, 3,4-dihydroxy-', 'Atamet', 'Levodopum [INN-Latin]', 'BDBM50130192', 'L-3', 'CCRIS 3766', 'HSDB 3348', 'WLN: QVYZ1R CQ DQ', '3,4-Dihydroxyphenylalanine (VAN)', 'SR-01000075384', 'EINECS 200-445-2', 'NSC 118381', 'L-3,4-Dihydrophenylalanine', 'Dopastone', 'Dopicar', 'Prolopa', 'UNII-46627O600J', 'Prestwick_185', 'Levodopa (Sinemet)', 'L-DOPA; Levodopa', 'Madopa (Salt/Mix)', 'Levodopa [USAN:USP:INN:BAN:JAN]', 'L-DOPA (Standard)', 'Spectrum_000454', '4-dihydroxyphenylalanine', 'LEVODOPA [HSDB]', 'LEVODOPA [USAN]', 'LEVODOPA [INN]', 'LEVODOPA [JAN]', 'LEVODOPA [MI]', 'LEVODOPA [VANDF]', 'Prestwick0_000017', 'Prestwick1_000017', 'Prestwick2_000017', 'Prestwick3_000017', 'Spectrum2_000496', 'Spectrum4_000539', 'Spectrum5_001899', 'Lopac-D-9628', 'Levodopa (JP15/USP)', 'LEVODOPA [MART.]', 'bmse000322', 'Epitope ID:150927', 'LEVODOPA [USP-RS]', 'LEVODOPA [WHO-DD]', 'LEVODOPA [WHO-IP]', 'DOPA, L-', '3, 4-Dihydroxyphenylalanine', 'Alanine,4-dihydroxyphenyl)-', 'LEVODOPA [EMA EPAR]', 'Lopac0_000454', 'SCHEMBL22655', 'BSPBio_000053', 'BSPBio_002354', 'KBioGR_001177', 'KBioSS_000934', 'L-4-5-Dihydroxyphenylalanine', 'MLS000028514', 'BIDD:GT0158', 'DivK1c_000452', 'SPECTRUM2300205', 'Levodopa (JP18/USP/INN)', 'SPBio_000391', 'SPBio_001974', 'LEVODOPA [EP IMPURITY]', 'LEVODOPA [ORANGE BOOK]', 'BPBio1_000059', 'GTPL3639', 'orb1310238', 'SCHEMBL3857245', 'LEVODOPA [EP MONOGRAPH]', 'b-(3,4-Dihydroxyphenyl)alanine', 'LEVODOPA [USP MONOGRAPH]', 'SCHEMBL29373537', 'WLN: QVYZ1R CQ DQ -L', '3, 4-Dihydroxy-L-phenylalanine', 'BDBM60928', 'HMS501G14', 'HY-N0304R', 'KBio1_000452', 'KBio2_000934', 'KBio2_003502', 'KBio2_006070', 'PARCOPA COMPONENT LEVODOPA', 'LEVODOPUM [WHO-IP LATIN]', 'MSK1487', 'Alanine,4-dihydroxyphenyl)-, L-', 'CARBILEV COMPONENT LEVODOPA', 'CHEBI:233994', 'DOPASNAP COMPONENT LEVODOPA', 'IPX203 COMPONENT LEVODOPA', 'L-(3, 4-Dihydroxyphenyl)alanine', 'NINDS_000452', 'GLXC-07334', 'HMS1568C15', 'HMS1922J14', 'HMS2090O08', 'HMS2093N04', 'HMS2095C15', 'HMS2230B04', 'HMS3261K10', 'HMS3712C15', 'Pharmakon1600-02300205', 'HY-N0304', 'IPX-203 COMPONENT LEVODOPA', 'Levodopa;3,4-Dihydroxyphenylalanine', 'b-(3,4-Dihydroxyphenyl)-L-alanine', 'Inbrija (levodopa inhalation powder)', 'LEVODOPA COMPONENT OF PARCOPA', 'LEVODOPA COMPONENT OF SINEMET', 'Tox21_110338', 'Tox21_500454', 'CCG-39571', 'HB1925', 'L-3-(3,4-dihydroxy-phenyl)alanine', 'L-3-(3,4-dihydroxyphenyl)-Alanine', 'NSC759573', 'PDSP1_001541', 'PDSP2_001525', 's1726', 'SBB017533', 'Alanine, 3-(3,4-dihydroxyphenyl)-', 'Alanine,4-dihydroxyphenyl)-, (-)-', 'LEVODOPA COMPONENT OF CARBILEV', 'AKOS010396267', 'b-(3,4-Dihydroxyphenyl)-a-L-alanine', 'L-b-(3,4-Dihydroxyphenyl)-a-alanine', 'L-DOPA (3,4-Dihydroxyphenylalanine)', '.beta.-(3, 4-Dihydroxyphenyl)alanine', 'AC-8432', 'CS-1945', 'DB01235', 'FD15635', 'LP00454', 'NSC-759573', 'SDCCGMLS-0066924.P001', 'SDCCGSBI-0050439.P004', 'IDI1_000452', 'NCGC00015384-01', 'NCGC00016270-01', 'NCGC00016270-06', 'NCGC00016270-07', 'NCGC00016270-09', 'NCGC00016270-10', 'NCGC00016270-22', 'NCGC00093869-04', 'NCGC00261139-01', 'AS-13287', 'BP-12850', 'SMR000058312', 'ST086623', 'SY010977', 'SBI-0050439.P003', 'L-(3, 4-Dihydroxyphenyl)-.alpha.-alanine', 'D0600', 'D9628', 'EU-0100454', 'NS00068395', 'EN300-52637', '59L927', 'Alanine, 3-(3, 4-dihydroxyphenyl)-, (-)-', 'C00355', 'D 9628', 'D00059', 'D70595', '3,4-Dihydroxy-L-phenylalanine, >=98% (TLC)', 'AB00052418-06', 'AB00052418-07', 'AB00052418_08', 'AB00052418_09', 'F358380', 'Q300989', '(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoicacid', 'SR-01000075384-1', 'SR-01000075384-4', 'SR-01000075384-6', 'SR-01000075384-7', 'BRD-K34730807-001-15-0', 'BRD-K34730807-001-16-8', 'BRD-K34730807-001-17-6', '(S)-2-Amino-3-(3,4-dihydroxy-phenyl)-propionic acid', 'F0347-4695', 'Levodopa, British Pharmacopoeia (BP) Reference Standard', 'Levodopa, European Pharmacopoeia (EP) Reference Standard', 'Z756440064', '(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acidL-dopa', '1E83F927-C221-46AA-B90A-81B33C5F3868', '3,4-Dihydroxy-L-phenylalanine, Vetec(TM) reagent grade, 98%', 'Levodopa, United States Pharmacopeia (USP) Reference Standard', '3,4-Dihydroxy-L-phenylalanine, certified reference material, TraceCERT(R)', 'Levodopa, Pharmaceutical Secondary Standard; Certified Reference Material', 'L-DOPA;(S)-2-Amino-3-(3,4-dihydroxyphenyl) propanoic acid;Levodopa;Sinemet;Parcopa', '122769-74-8', '65170-01-6'] |
From Pubchem